Animal studies often fail to predict human tissue responses to new drugs or newly developed therapies. Besides generating tremendous costs for clinical studies, it also raises significant ethical ...
A biotech company which aims to revolutionise drug testing using lab-grown human muscles has secured the backing of a seed-stage investor to accelerate its growth.
A biotechnology start-up developing lab-grown human muscle tissue has secured £325,000 in investment to accelerate its technology. Myomaker Bio, a spin-out from Loughborough University, has raised the ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する